H&Q Healthcare Investors and H&Q Life Sciences Investors Announce Investor Information Seminar
H&Q Healthcare Investors and H&Q Life Sciences Investors Announce Investor Information Seminar
BOSTON--(BUSINESS WIRE)-- H&Q Healthcare Investors and H&Q Life Sciences Investors invite you to attend or participate via webcast an Investor Information Seminar on Friday, June 7, 2013, at 8:30 a.m. The Seminar will be held at the Downtown Club of Boston, 38th Floor, Boston, Massachusetts.
The Investor Information Seminar will include:
Comments by the Portfolio Manager
Presentations by Portfolio Companies
Panel Discussion:Cost of New Therapies in Disease
Key Note Speaker:Dr. Robert Weinberg
Please RSVP to or obtain webcast information at www.teklacap.com or (617) 772-8500.
H&Q Healthcare Investors (NYS: HQH) is a closed-end fund that invests in public and private companies in the healthcare industry. Tekla Capital Management LLC, based in Boston, serves as Investment Adviser to the Fund. Shares of the Fund can be purchased on the New York Stock Exchange through any securities broker.
H&Q Life Sciences Investors (NYS: HQL) is a closed-end fund that invests in public and private companies in the life sciences industry. Tekla Capital Management LLC, based in Boston, serves as Investment Adviser to the Fund. Shares of the Fund can be purchased on the New York Stock Exchange through any securities broker.
For additional information, please consult www.teklacap.com or call (617) 772-8500.
H&Q Healthcare Investors
H&Q Life Sciences Investors
617-772-8500
www.teklacap.com
KEYWORDS: United States North America Massachusetts
INDUSTRY KEYWORDS:
The article H&Q Healthcare Investors and H&Q Life Sciences Investors Announce Investor Information Seminar originally appeared on Fool.com.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.
